Pancreatic Cancer Research

ResearcherWuxi People's HospitalNo recent work listed

Qiang Zhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2618-5475; OpenAlex author ID A5033184348. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2022: 4 papers · 2023: 1 paper

Papers 5

  1. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mc.23554↗
  2. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer. Last author DOI 10.1186/s12885-022-09294-w↗
  3. Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer. Co-author DOI 10.1186/s12885-022-09639-5↗
  4. FMNL3 is Overexpressed in Tumor Tissues and Predicts an Immuno-Hot Phenotype in Pancreatic Cancer. Last author DOI 10.2147/ijgm.s384195↗
  5. Dishevelled-Associated Activator of Morphogenesis 2 (DAAM2) Predicts the Immuno-Hot Phenotype in Pancreatic Adenocarcinoma. Last author DOI 10.3389/fmolb.2022.750083↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qinglin Zhang · 2 shared papers, 2022 · strength 0.39
  2. Shuping Si · 1 shared paper, 2022 · strength 0.20
  3. Lei Wang · 1 shared paper, 2022 · strength 0.20
  4. Fangmei An · 1 shared paper, 2022 · strength 0.19
  5. Ying Lv · 1 shared paper, 2023 · strength 0.17
  6. Yixuan Zhang · 1 shared paper, 2023 · strength 0.17
  7. Hui Wang · 1 shared paper, 2023 · strength 0.17
  8. Shanshan Shen · 1 shared paper, 2023 · strength 0.17
  9. Shu Zhang · 1 shared paper, 2023 · strength 0.17
  10. Xiaoping Zou · 1 shared paper, 2023 · strength 0.17
  11. Jiayue Yang · 1 shared paper, 2022 · strength 0.16
  12. Cheng Yang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.